Kura Oncology Grants 53,000 Stock Options to 4 New Employees

Kura Oncology, Inc. announced that its Compensation Committee granted inducement awards consisting of 53,000 nonstatutory stock options to four new employees on June 1, 2026. The options have an exercise price of $9.04 per share, which was the closing price of the company's common stock on the grant date. These awards will vest over four years, with 25% vesting on the one-year anniversary and the remainder vesting monthly over 36 months, subject to continued employment.